KEAP1 mutation often disrupts the interaction of KEAP1/NFE2L2/CUL3, and its disability leads to the promotion of tumor genesis through the abnormal activation of NFE2L2.5, 6. The gene discussed is NFE2L2; the disease is neoplasm.